Study to Evaluate Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Hemorrhoids
Interventions
DRUG

Bupivacaine HCl

100 mg Bupivacaine HCl

DRUG

SKY0402

Single administration 300 mg SKY0402 in a 40-mL injection volume

Trial Locations (20)

10029

Mount Sinai Hospital, New York

10467

Montefiore Medical Center, The Bronx

27710

Duke University Medical Center, Durham

27834

CTMG, Inc. - Pitt Medical Center, Greenville

32804

Colon and Rectal Disease Center, Orlando

35209

West Alabama Research Inc., Birmingham

36106

Drug Research and Analysis Corporation, Montgomery

37660

Holston Medical Group, Kingsport

40202

University of Louisville, Louisville

44106

Univ. Hospitals of Cleveland, Case Medical Center, Cleveland

46202

Indiana University - Wishard Memorial Hospital, Indianapolis

77054

Medical Center Ambulatory Surgery Center, Houston

The Women's Hospital of Texas, Houston

77401

Research Concepts, Ltd, Bellaire

78205

Roland Saenz, San Antonio

91105

Lotus Clinical Research - Huntington Memorial Hospital, Pasadena

92121

UCSD Medical Center, San Diego

92672

Accurate Clinical Trials, San Clemente

98405

Multicare Health System, Tacoma

62708-0787

University of Illinois, Springfield

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY